Anaesthesia and Intensive Care · 1985 · 10 citations · 8 references
MedicineAnesthesiologySurgeryAnesthesiaAnesthetic TechniquesGeneral AnesthesiaNeuromuscular BlockadeNeuromuscular Blocking AgentsBradycardia During AnesthesiaIntubating ConditionsMuscle Relaxant EffectsMuscle Relaxant TherapyNeostigmine ReversalSurgical Relaxation
In a double-blind, prospective, randomised trial in 51 female patients, atracurium 0.6mg/kg provided acceptable intubating conditions more rapidly than did alcuronium 0.25 mg/kg. Atracurium produced more profound neuromuscular twitch suppression than alcuronium. The effect of atracurium was longer-lasting than that of alcuronium (32 minutes and 22 minutes respectively to achieve 10% recovery) and it took slightly longer to reverse with neostigmine. Seven patients in the atracurium group who underwent short surgical procedures required supplementary neostigmine to achieve adequate reversal. Two cases of sinus bradycardia were noted in the atracurium group, but hypotension was not a clinical problem in any patient. Atracurium appears to be a useful relaxant, but a smaller dose than that used here should be chosen for short procedures.
8
Clinical pharmacology of atracurium besylate (BW 33A): a new non-depolarizing muscle relaxant.
S. J. Basta, Hassan H. Ali, John J. Savarese et al. · PubMed · 1982 · 127 citations
Clinical Pharmacology of Atracurium Besylate (BW 33A)
S. J. Basta, Hassan H. Ali, John J. Savarese et al. · Anesthesia & Analgesia · 1982 · 110 citations